RT Journal Article
SR Electronic
T1 Quantifying COVID-19 vaccination hesitancy during early vaccination rollout in Canada
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.29.21256333
DO 10.1101/2021.04.29.21256333
A1 Tang, Xuyang
A1 Gelband, Hellen
A1 Nagelkerke, Nico
A1 Bogoch, Isaac I.
A1 Brown, Patrick
A1 Morawski, Ed
A1 Tam, Theresa
A1 Reid, Angus
A1 Jha, Prabhat
A1 ,
YR 2021
UL http://medrxiv.org/content/early/2021/05/02/2021.04.29.21256333.abstract
AB Background Understanding vaccination hesitancy during early vaccination rollout in Canada can help the government’s vaccination efforts in education and outreach, which may help eventually achieving herd immunity. This study uses an online survey to assess vaccination hesitancy in population subgroups in Canada.Method Panel members from the nationally representative Angus Reid Forum were randomly invited to complete an online survey on their experiencing with COVID-19 symptoms and testing, as well as intention to vaccination against COVID-19. Respondents were asked “when a vaccine against the coronavirus becomes available to you, will you get vaccinated or not?” Vaccination hesitancy was defined as choosing “No – I will not get a coronavirus vaccination” as a response.Results 14,621 panel members (46% male and 53% female) completed the survey. Although the respondents overrepresent age 60+ and higher levels of education, other demographics, the prevalences of smoking, obesity, diabetes and hypertension were comparable to the Canadian national census and health surveys. COVID-19 vaccination hesitancy is relatively low overall (9%). Being a resident of Alberta (predicted probability = 15%), aged 40-59 (OR = 0.87, 0.78 – 0.97, predicted probability = 12%), identifying as a visible minority (OR = 0.56, 0.37 – 0.84, predicted probability = 15%), having some college level education or lower (predicted probability = 14%), or living in households of at least 5 are related to greater vaccination hesitancy (OR = 0.82, 0.76 – 0.88, predicted probability = 13%).Conclusion Our study enhances the understanding of COVID-19 vaccination hesitancy and identifies key population groups with higher vaccination hesitancy. As the Canadian COVID-19 vaccination effort continues, policymakers may focus outreach, education, and other efforts on these groups, which also represent groups with higher risks for contracting and dying from COVID-19. Furthermore, Canada would need to vaccinate virtually the entire population to reach herd immunity due to its relatively low infection level, and a high vaccination hesitancy would be a major hurdle to achieving that.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research was funded by an unrestricted grant from Pfizer Global Medical Grants, Unity Health Foundation and the Canadian COVID-19 Immunity Task Force. The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is approved by the Unity Health Toronto Ethics Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon request pending approval from the Unity Health Toronto Ethics Review Board and the COVID-19 Immunity Task Force.